AYTU
Aytu BioPharmaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
AYTU vs peer average
92/100
AYTU vs. peer average (A vs. D)
Grade spread
B 2 · C 3 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AXSM is the first available peer comparator.
Axsome's marketed major-depressive-disorder treatment AUVELITY offers a therapeutic-adoption reference for EXXUA, but its much larger commercial scale makes it unsuitable as a direct AYTU valuation multiple. [Axsome earnings exhibit](https://www.sec.gov/Archives/edgar/data/1579428/000119312526341206/axsm-ex99_1.htm)
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AYTU
Aytu BioPharma
AXSM
Axsome Therapeutics
Grade
A
C
Momentum
100
11
Value
53
41
Sentiment
63
78
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs AXSM
AYTU / AXSM
Grade Position
Above peers
AYTU vs. peer average (A vs. D)
92/100
Momentum
100
AYTUValue
53
AYTUSentiment
63
AXSMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AYTU
AXSM is the first peer returned for this comparison set.